Update on EGFR-mutated non-small cell lung cancer

Get full text

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Get full text

The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

Get full text

The role of exosomes in multiple myeloma development & drug resistance

Get full text
Series

Drug metabolizing enzymes in cancer therapeutics

Get full text
Series

Latest development in therapy-related autophagy research

Get full text
Series

Mitochondrial inhibition as a novel therapeutic approach in drug-resistant cancer

Get full text

Overview of clinical pharmacology in cancer part 1 of 2 /

Get full text
Series

Key considerations for cancer pharmacotherapy part 1 of 2 /

Get full text
Series

Novel treatment options in lymphoma and leukemia part 1 of 2 /

Get full text
Series

Overview of clinical pharmacology in cancer part 2 of 2 /

Get full text
Series

Novel treatment options in lymphoma and leukemia part 2 of 2 /

Get full text
Series

Key considerations for cancer pharmacotherapy part 2 of 2 /

Get full text
Series

Cytochrome P450 1 family the roles of 1A1, 1A2 and 1B1 in drug metabolism /

Get full text
Series

Immune checkpoint blockade in renal cell carcinoma

Get full text
Series (Immunotherapy of cancer)
Series (Kidney in health and disease)

Immune checkpoint blockade in CNS tumors

Get full text
Series

Genomics of lung cancer

Get full text
Series

Pharmacogenomics in cancer therapy

Get full text
Series

Functional cancer genomics

Get full text
Series

Current trends in antiviral drug development

Get full text
Series (Antivirals)
Series (Small molecule drug discovery)